VectivBio Holding AG Ordinary Shares
VECT
VECT was delisted on the 7th of July, 2023.
49 hedge funds and large institutions have $504M invested in VectivBio Holding AG Ordinary Shares in 2023 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 23 closing their positions.
61% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 23
42% more call options, than puts
Call options by funds: $460K | Put options by funds: $324K
40% more funds holding
Funds holding: 35 → 49 (+14)
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
38% more capital invested
Capital invested by funds: $365M → $504M (+$139M)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$24.6M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$24.3M |
| 3 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$23.7M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$16.9M |
| 5 |
VI
Versor Investments
New York
|
+$15.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$52.1M |
| 2 |
CA
CHI Advisors
New York
|
-$32.5M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$31.6M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$30.7M |
| 5 |
B
Bpifrance
Maisons Alfort, Cedex,
France
|
-$23.9M |
VECT Hedge Fund Activity: Q2 2023 in Review
49 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in VectivBio Holding AG Ordinary Shares (VECT) for Q2 2023, worth a combined $504M — up 38% from $365M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new VECT positions and 23 closed out — a net gain of 14 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $24.6M. The largest seller was Citadel Advisors, cutting an estimated $52.1M.
- 49 institutional investors held VectivBio Holding AG Ordinary Shares (VECT) as of Q2 2023, up from 35 in Q1 2023.
- Funds reported $504M of VectivBio Holding AG Ordinary Shares stock for Q2 2023, up 38% quarter-over-quarter.
- 37 funds opened new VectivBio Holding AG Ordinary Shares positions in Q2 2023 and 23 closed out, a net change of +14 holders.
- The largest VectivBio Holding AG Ordinary Shares buyer in Q2 2023 was Glazer Capital LLC, an estimated $24.6M added.
- The largest VectivBio Holding AG Ordinary Shares seller in Q2 2023 was Citadel Advisors, an estimated $52.1M sold.
Based on aggregated 13F filings for Q2 2023.